Convelo Therapeutics
PrivateLast Round
Series B
Dec 8, 2022
Total Funding Raised
$34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Convelo Therapeutics is a biotechnology company developing a new class of medicines that unlock the regenerative capacity of the central nervous system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Convelo Therapeutics Comparables
Compare Convelo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Progentos Therapeutics | 92% | |
| Rewind Therapeutics | 92% | |
| Pheno Therapeutics | 90% |
Convelo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 8, 2022 | ||||
| Series A | Jul 25, 2018 | ||||
| Seed | Dec 5, 2017 |
Convelo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JumpStart | Series B |
| JumpStart Inc. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 257% MoM.
- May 18, 2026
Monthly visitors increased 372% MoM.
Convelo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Convelo Therapeutics's valuation, stock price, and market status.
Is Convelo Therapeutics a public or private company?
Convelo Therapeutics is a private company.
What is the current stock price of Convelo Therapeutics?
Convelo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Convelo Therapeutics worth (valuation)?
Valuation information for Convelo Therapeutics is not publicly available.
Can I buy Convelo Therapeutics stock?
Convelo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Convelo Therapeutics's last funding round?
Convelo Therapeutics's most recent funding round was Series B on December 8, 2022.
Who are the main investors in Convelo Therapeutics?
Key investors in Convelo Therapeutics include JumpStart Inc..
Will Convelo Therapeutics IPO soon?
No public IPO plans have been announced for Convelo Therapeutics.
How can I track Convelo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Convelo Therapeutics's secondary market activity and sign up for updates.